Log in

Relevant bibliographies by topics / Placenta accreta spectrum disorders / Journal articles

To see the other types of publications on this topic, follow the link: Placenta accreta spectrum disorders.

Journal articles on the topic 'Placenta accreta spectrum disorders'

Author: Grafiati

Published: 2 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Placenta accreta spectrum disorders.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Rajeswari, K. S. Raja, Pavithraa Parthiban, and Kiruba Hannah Vidhyantha. "Clinical perspectives on placenta accreta spectrum: a case series." International Journal of Reproduction, Contraception, Obstetrics and Gynecology 14, no. 1 (2024): 234–36. https://doi.org/10.18203/2320-1770.ijrcog20243957.

Full text

Abstract:

To describe the presentation and management of three cases of placenta accreta spectrum. Placenta accreta spectrum (PAS), first described in 1937, refers to the pathological invasion of placental trophoblasts into the myometrium and beyond. While a strong association exists between PAS and uterine scarring-often attributed to defective decidualization at the endometrium-myometrium interface-this does not fully explain all cases. Here we report three cases of placenta accreta spectrum disorders, two cases with placenta accreta and one with placenta percreta. Emergency LSCS was performed for two

APA, Harvard, Vancouver, ISO, and other styles

2

Phetrat, Nawaporn, Savitree Pranpanus, Thitima Suntharasaj, and Chusana Petpichetchian. "Risk factors for emergent delivery before 36 weeks among pregnant women with placenta accreta spectrum disorder." PLOS One 20, no. 4 (2025): e0321617. https://doi.org/10.1371/journal.pone.0321617.

Full text

Abstract:

Recent studies evaluating risk factors for emergent delivery in women with placenta accreta spectrum disorders have yielded insufficient results. A limited number of studies have evaluated prenatal ultrasound signs of the placenta accreta spectrum as risk factors and have reported inconsistent outcomes. This retrospective study included women with suspected prenatal placenta accreta spectrum who delivered between January 2007 and December 2022 at a tertiary hospital in Southern Thailand. Women who delivered electively or for conditions unrelated to the placenta accreta spectrum before 36 weeks

APA, Harvard, Vancouver, ISO, and other styles

3

Cal, Margarida, Carla Nunes, Nuno Clode, and Diogo Ayres-de-Campos. "Placenta Accreta Overlying a Caesarean Section Scar: A 10-Year Experience in a Tertiary-Care Centre in Portugal." Acta Médica Portuguesa 34, no. 4 (2021): 266. http://dx.doi.org/10.20344/amp.14001.

Full text

Abstract:

Introduction: Placenta accreta spectrum disorders are among the leading causes of maternal morbidity and mortality and their prevalence is likely to increase in the future. The risk of placenta accreta spectrum disorders is highest in cases of placenta previa overlying a previous cesarean section scar. Few studies have evaluated placenta accreta spectrum disorders in Portugal. The aim of this study was to review the cases of placenta accreta spectrum overlying a cesarean section scar managed in a Portuguese tertiary center over the last decade.Material and Methods: Retrospective, cross-section

APA, Harvard, Vancouver, ISO, and other styles

4

Lumbanraja, Sarma, M. Rizki Yaznil, Andre M. Siahaan, Berry E. P. Bancin, and Dizalia Ananda. "Placental Growth Factor-soluble FMS-like Tyrosine Kinase-1 Ratio in Placenta Accreta Spectrum Disorder: Case Control Study." Open Access Macedonian Journal of Medical Sciences 10, B (2022): 848–52. http://dx.doi.org/10.3889/oamjms.2022.8754.

Full text

Abstract:

AIM: The aim of the study was to assess the ratio of placental growth factor (PLGF)/soluble FMSlike tyrosine kinase (sFLT-1) as a marker for in placenta accreta spectrum disorder stage. METHODS: We enrolled 50 participants in this study, 25 participants diagnosed with placenta accreta spectrum disorder and 25 participants with normal pregnancy as controls. Diagnosis is based on ultrasonographic criteria from the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) for spectrum disorders of placenta accreta. Up to 3 cc peripheral venous blood was taken before cesarean sectio

APA, Harvard, Vancouver, ISO, and other styles

5

Lumbanraja, Sarma, M. Rizki Yaznil, Andre M. Siahaan, and Bancin Berry Eka Parda. "Soluble FMS-Like Tyrosine Kinase: Role in placenta accreta spectrum disorder." F1000Research 10 (July 21, 2021): 618. http://dx.doi.org/10.12688/f1000research.54719.1.

Full text

Abstract:

Background: Placenta accreta is a pregnancy condition where the placenta's blood vessels attach too deeply to the uterine wall. Incidence of placenta accreta is increasingly seen today as the rate of cesarean section increases, however, the exact pathophysiology of this condition is still not fully understood. Soluble fms-like tyrosine kinase-1 (sflt-1) as a protein produced by the placenta was found to be decreased in placenta accreta, Therefore we aim to see if sflt-1 has a role in the development of placenta accreta. Methods: This study involved 40 samples from patients that had been diagno

APA, Harvard, Vancouver, ISO, and other styles

6

Lumbanraja, Sarma, M. Rizki Yaznil, Andre M. Siahaan, and Bancin Berry Eka Parda. "Soluble FMS-Like Tyrosine Kinase-1: Role in placenta accreta spectrum disorder." F1000Research 10 (September 7, 2022): 618. http://dx.doi.org/10.12688/f1000research.54719.4.

Full text

Abstract:

Background: Placenta accreta is a pregnancy condition where the placenta's blood vessels attach too deeply to the uterine wall. Incidence of placenta accreta is increasingly seen today as the rate of cesarean section increases, however, the exact pathophysiology of this condition is still not fully understood. Soluble fms-like tyrosine kinase-1 (sflt-1) as a protein produced by the placenta was found to be decreased in placenta accreta, Therefore we aim to see if sfltsFlt-1 has a role in the development of placenta accreta. Methods: This study involved 40 samples from patients that had been di

APA, Harvard, Vancouver, ISO, and other styles

7

Lumbanraja, Sarma, M. Rizki Yaznil, Andre M. Siahaan, and Bancin Berry Eka Parda. "Soluble FMS-Like Tyrosine Kinase-1: Role in placenta accreta spectrum disorder." F1000Research 10 (November 30, 2021): 618. http://dx.doi.org/10.12688/f1000research.54719.3.

Full text

Abstract:

Background: Placenta accreta is a pregnancy condition where the placenta's blood vessels attach too deeply to the uterine wall. Incidence of placenta accreta is increasingly seen today as the rate of cesarean section increases, however, the exact pathophysiology of this condition is still not fully understood. Soluble fms-like tyrosine kinase-1 (sflt-1) as a protein produced by the placenta was found to be decreased in placenta accreta, Therefore we aim to see if sfltsFlt-1 has a role in the development of placenta accreta. Methods: This study involved 40 samples from patients that had been di

APA, Harvard, Vancouver, ISO, and other styles

8

Lumbanraja, Sarma, M. Rizki Yaznil, Andre M. Siahaan, and Bancin Berry Eka Parda. "Soluble FMS-Like Tyrosine Kinase-1: Role in placenta accreta spectrum disorder." F1000Research 10 (September 6, 2021): 618. http://dx.doi.org/10.12688/f1000research.54719.2.

Full text

Abstract:

Background: Placenta accreta is a pregnancy condition where the placenta's blood vessels attach too deeply to the uterine wall. Incidence of placenta accreta is increasingly seen today as the rate of cesarean section increases, however, the exact pathophysiology of this condition is still not fully understood. Soluble fms-like tyrosine kinase-1 (sflt-1) as a protein produced by the placenta was found to be decreased in placenta accreta, Therefore we aim to see if sfltsFlt-1 has a role in the development of placenta accreta. Methods: This study involved 40 samples from patients that had been di

APA, Harvard, Vancouver, ISO, and other styles

9

JAUNIAUX, ERIC, and GRAHAM J. BURTON. "Pathophysiology of Placenta Accreta Spectrum Disorders." Clinical Obstetrics and Gynecology 61, no. 4 (2018): 743–54. http://dx.doi.org/10.1097/grf.0000000000000392.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Natarajan, Sundari, and Deepika Nagarajan. "Comparison between ultrasound and MRI in antenatal diagnosis of adherent placenta." International Journal of Reproduction, Contraception, Obstetrics and Gynecology 14, no. 1 (2024): 172–77. https://doi.org/10.18203/2320-1770.ijrcog20243945.

Full text

Abstract:

Background: Placental imaging using ultrasonography and MRI with various parameters provides information about abnormal placentation. Prenatal diagnosis of placenta accreta spectrum disorder (PAS) is of paramount importance to minimize complication rate and improve outcome of delivery. The aim of our study is to compare the accuracy between ultrasound and MRI in antenatal diagnosis of adherent placenta. Methods: Prospective study was conducted on 50 pregnant women with persistent placenta previa (after 28 weeks of gestation) at Madurai Medical college and Government Rajaji Hospital for period

APA, Harvard, Vancouver, ISO, and other styles

11

An, Peng, Junyan Zhang, Feng Yang, Zhongqiu Wang, Yan Hu, and Xiumei Li. "USMRI Features and Clinical Data-Based Model for Predicting the Degree of Placenta Accreta Spectrum Disorders and Developing Prediction Models." International Journal of Clinical Practice 2022 (January 31, 2022): 1–9. http://dx.doi.org/10.1155/2022/9527412.

Full text

Abstract:

Aim. This study aimed to investigate the ability of ultrasound/magnetic resonance imaging (MRI) signature and clinical data-based model for preoperatively predicting the degree of placenta accreta spectrum disorders and develop combined prediction models. Methods. The clinicopathological characteristics, prenatal ultrasound images, and MRI features of 132 pregnant women with placenta accreta spectrum disorders at Xiangyang No. 1 People’s Hospital were retrospectively reviewed from January 2016 to December 2020. In the training set of 99 patients, the ultrasound/MRI features model, clinical cha

APA, Harvard, Vancouver, ISO, and other styles

12

Malik, Renuka, Swati Singh, Jaya Chawla, and Meenakshi Bhardwaj. "Placenta accreta not previa: a rare case report of placenta accreta in an unscarred uterus." International Journal of Reproduction, Contraception, Obstetrics and Gynecology 8, no. 12 (2019): 5050. http://dx.doi.org/10.18203/2320-1770.ijrcog20195370.

Full text

Abstract:

Placenta accreta spectrum disorders are usually associated with direct surgical scar such as caesarean delivery, surgical termination of pregnancy, Dilatation and curettage, Myomectomy, Endometrial resection and Asherman’s syndrome. It can also be associated with non-surgical scar and uterine anomalies. Rarely it can be encountered in unscarred uterus. Mrs X, 35-year female, unbooked patient, G7P2L2A4 with nine months of amenorrhoea reported in emergency of RML Hospital on 30/07/2019 with history of labour pains since 2 days. Patient gave history of four dilatation and curettage for incomplete

APA, Harvard, Vancouver, ISO, and other styles

13

Einerson, Brett D., Jessica Comstock, Robert M. Silver, D. Ware Branch, Paula J. Woodward, and Anne Kennedy. "Placenta Accreta Spectrum Disorder." Obstetrics & Gynecology 135, no. 5 (2020): 1104–11. http://dx.doi.org/10.1097/aog.0000000000003793.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Kumari, Maya, Amrita D. Patel, and Vishrut Mashruwala. "Case series on placenta accreta spectrum disorder and its management." International Journal of Reproduction, Contraception, Obstetrics and Gynecology 13, no. 7 (2024): 1825–30. http://dx.doi.org/10.18203/2320-1770.ijrcog20241781.

Full text

Abstract:

Placenta accreta spectrum (PAS) is a potentially life-threatening obstetric condition that requires a multidisciplinary approach to management. The main complication of PAS is due to it’s massive obstetric haemorrhage which leads to maternal morbidity and mortality. The incidence of placenta accreta spectrum increases day by day due to an alarming increase in caesarean section rates. Depending on the range of invasiveness, The Placenta accreta spectrum is classified as placenta accreta, placenta increta and placenta percreta. We report here a series of 5 cases of placenta accreta spectrum and

APA, Harvard, Vancouver, ISO, and other styles

15

Munoz, J. L., L. M. Blankenship, P. S. Ramsey, and G. A. McCann. "Implementation and Outcomes of a Uterine Artery Embolization and Tranexamic Acid Protocol for Placenta Accreta Spectrum." Obstetric Anesthesia Digest 44, no. 2 (2024): 88. http://dx.doi.org/10.1097/01.aoa.0001016028.15303.42.

Full text

Abstract:

(Am J Obstet Gynecol. 2023;229(1):61.e1–61.e7) During pregnancy, complications may arise such as placenta accreta spectrum (PAS) disorders. PAS is a continuum of conditions characterized by abnormal placental invasion, posing intraoperative risks during delivery. Patients with PAS often face postpartum complications, typically necessitating scheduled cesarean deliveries (CD) between 34 and 36 weeks gestation, making the delivery high risk. High blood loss and post-CD complications are common in women with placenta accreta, prompting the implementation of specific observations and protocols in

APA, Harvard, Vancouver, ISO, and other styles

16

Greenberg, Victoria R., Joshua Copel, Urania Magriples, Jennifer Wong, Katherine Kohari, and Audrey Merriam. "Ultrasound prediction of placenta accreta spectrum disorders." American Journal of Obstetrics and Gynecology 226, no. 1 (2022): S585. http://dx.doi.org/10.1016/j.ajog.2021.11.967.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Létourneau, Isabelle, Sebastian R. Hobson, Felipe Moretti, et al. "Placenta accreta spectrum disorders: A national survey." Journal of Obstetrics and Gynaecology Canada 45, no. 5 (2023): 360. http://dx.doi.org/10.1016/j.jogc.2023.03.063.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Golianovskyi, O. V., I. M. Ivankova, and Yu V. Slobodian. "Placenta praevia and Placenta accreta: modern methods of diagnosis and delivery." HEALTH OF WOMAN, no. 3(139) (April 30, 2019): 8–14. http://dx.doi.org/10.15574/hw.2019.139.8.

Full text

Abstract:

The article presents data from recent randomized trials and published in 2018 two guidelines from the Royal College of Obstetricians and Gynecologists of Great Britain on epidemiology, risk factors, modern diagnostic methods, modern algorithms and innovative surgical methods in cases of placenta (pl. praevia/accreta). From the point of view of evidence-based medicine, the relevance of the problem in the aspect of antenatal diagnosis of placental pathology for prediction and prevention of life-threatening hemorrhagic complications is highlighted. Data are presented indicating the need for a mul

APA, Harvard, Vancouver, ISO, and other styles

19

Lu, Tao, Hang Li, Li Wang, Mou Li, and Yishuang Wang. "Impact of placental location matter in placenta accreta spectrum disorders." Quantitative Imaging in Medicine and Surgery 14, no. 12 (2024): 9086–100. https://doi.org/10.21037/qims-24-443.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Bahuguna, Yash, Prachi Koranne, and Aparna Wahane. "A COMPARATIVE ANALYTICAL STUDY OF MATERNAL MORBIDITY AND MORTALITY INDICATORS BETWEEN PLACENTA ACCRETA SPECTRUM (PAS) AND NORMAL PLACENTATION DURING CAESAREAN SECTION." International Journal of Advanced Research 11, no. 12 (2023): 405–11. http://dx.doi.org/10.21474/ijar01/18000.

Full text

Abstract:

Introduction: The Placenta Accreta Spectrum (PAS) has emerged as a complex and increasingly prevalent condition, presenting formidable challenges in the field of obstetrics. PAS refers to a range of pathological conditions characterized by abnormal placental attachment to the uterine wall, leading to potentially life-threatening complications during pregnancy and childbirth. This condition has garnered significant attention from researchers, clinicians, and healthcare providers due to its rising incidence and the critical management decisions it demands. Methods: This was a Case-Control study

APA, Harvard, Vancouver, ISO, and other styles

21

Singh, Shivangee, Renu Gupta, Pavika Lal, et al. "PREVALENCE, RISK FACTORS AND FETO-MATERNAL OUTCOME OF PLACENTA ACCRETA SPECTRUM AT A TERTIARY CARE CENTRE." International Journal of Advanced Research 12, no. 12 (2024): 170–75. https://doi.org/10.21474/ijar01/20011.

Full text

Abstract:

Introduction: Placenta Accreta Spectrum disorders, characterized by abnormal adherence of the placenta to the uterine wall, represent a significant obstetric challenge due to their association with severe maternal hemorrhage and increased maternal morbidity and mortality. Material and Methods: This ambispective observational study was conducted over 4.5 years at the Upper India Sugar Exchange Maternity Hospital, GSVM Medical College, Kanpur. The study included 70 patients diagnosed with Placenta Accreta Spectrum (PAS) disorders, with data collected retrospectively for January 2020 - December 2

APA, Harvard, Vancouver, ISO, and other styles

22

Cavalli, Cecilia, Claudia Maggi, Sebastiana Gambarini, et al. "Ultrasound and magnetic resonance imaging in the diagnosis of clinically significant placenta accreta spectrum disorders." Journal of Perinatal Medicine 50, no. 3 (2021): 277–85. http://dx.doi.org/10.1515/jpm-2021-0334.

Full text

Abstract:

Abstract Objectives We aimed to assess the performance of ultrasound (US) and magnetic resonance imaging (MRI) signs for antenatal detection of placenta accreta spectrum (PAS) disorders in women with placenta previa (placental edge ≤2 cm from the internal uterine orifice, ≥260/7 weeks’ gestation) with and without a history of previous Caesarean section. Methods Single center prospective observational study. US suspicion of PAS was raised in the presence of obliteration of the hypoechoic space between uterus and placenta, interruption of the hyperechoic uterine-bladder interface and/or turbulen

APA, Harvard, Vancouver, ISO, and other styles

23

Giouleka, Sonia, Ioannis Tsakiridis, Evangelia-Rafaela Chanioti, et al. "Placenta Accreta Spectrum: A Comprehensive Review of Guidelines." Obstetrical & Gynecological Survey 79, no. 6 (2024): 366–81. http://dx.doi.org/10.1097/ogx.0000000000001274.

Full text

Abstract:

ABSTRACT Importance Placenta accreta spectrum (PAS) represents a range of disorders characterized by abnormal placental invasion and is associated with severe maternal morbidity and mortality. Objective The aim of this study was to review and compare the most recently published major guidelines on the diagnosis and management of this potentially life-threatening obstetric complication. Evidence Acquisition A descriptive review of guidelines from the American College of Obstetricians and Gynecologists, the Royal Australian and New Zealand College of Obstetricians and Gynecologists, the Internat

APA, Harvard, Vancouver, ISO, and other styles

24

Khandelwal, Meena, Thomas D. Shipp, Carolyn M. Zelop, et al. "Imaging the Uterus in Placenta Accreta Spectrum Disorder." American Journal of Perinatology 40, no. 09 (2023): 1013–25. http://dx.doi.org/10.1055/s-0043-1761914.

Full text

Abstract:

Antenatal diagnosis of placenta accreta spectrum (PAS) improves maternal and neonatal outcomes by allowing for multidisciplinary planning and preparedness. Ultrasound is the primary imaging tool. Simplification and standardization of placental evaluation and reporting terminology allows improved communication and understanding between teams. Prior to 10 weeks of gestation, gestational sac position and least myometrial thickness surrounding the gestational sac help PAS diagnosis very early in pregnancy. Late first-, second-, and third-trimester evaluation includes comprehensive evaluation of th

APA, Harvard, Vancouver, ISO, and other styles

25

Dinata, Willy Angga, Alini Hafiz, Arufiadi Anityo Mochtar, Julian Dewantiningrum, Putri Sekar Wiyati, and Ratnasari Dwi Cahyanti. "Comparison Between Placenta Accreta Index and Tovbin Score as A Predictor of Placenta Accreta Spectrum Disorders (PASD)." Medica Hospitalia : Journal of Clinical Medicine 11, no. 1 (2024): 26–32. http://dx.doi.org/10.36408/mhjcm.v11i1.980.

Full text

Abstract:

Background : The incidence of Placenta Accreta Spectrum Disorders (PASD) in developed countries has reportedly increased 10-fold in the last 50 years. The significant increase was followed by an increase in the number of caesarean section from 12.5% to 23.5% in the last 10 years. Maternal morbidity related to PASD events reaches 7% in intraoperative and postoperative actions, while the morbidity reaches 60%. In cases of late diagnosis, maternal mortality with placenta accreta reaches 30%. Efforts to prevent maternal morbidity and mortality can be carried out by early detection at antenatal car

APA, Harvard, Vancouver, ISO, and other styles

26

Jauniaux, Eric, Robert M. Silver, and Shigeki Matsubara. "The new world of placenta accreta spectrum disorders." International Journal of Gynecology & Obstetrics 140, no. 3 (2018): 259–60. http://dx.doi.org/10.1002/ijgo.12433.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Gadappa, Shrinivas N., Rupali A. Gaikwad, Anurag A. Sonawne, Ankita R. Shah, Shrutika O. Makde, and Sowjanya S. B. "Placenta accreta in a referred post hysterotomy case: a bold step into the unknown." International Journal of Reproduction, Contraception, Obstetrics and Gynecology 10, no. 2 (2021): 765. http://dx.doi.org/10.18203/2320-1770.ijrcog20210338.

Full text

Abstract:

Placenta accreta spectrum encompasses a range of pathological adherence of placenta and causes significant maternal and neonatal morbidity and mortality. With the increase in the number of cesarean deliveries over the last few decades, there has been an 8 fold increase in the incidence of placenta accreta. The single most important risk factor reported in about half the cases of PAS disorders is placenta previa. Management involves a standardized approach with a comprehensive multidisciplinary care team accustomed to management of placenta accreta. We discuss a rare case of a patient who under

APA, Harvard, Vancouver, ISO, and other styles

28

Gloria, Calagna, Polito Salvatore, Labate Francesco, et al. "Placenta Accreta Spectrum Disorder in a Patient with Six Previous Caesarean Deliveries: Step by Step Management." Case Reports in Obstetrics and Gynecology 2021 (September 12, 2021): 1–4. http://dx.doi.org/10.1155/2021/2105248.

Full text

Abstract:

The definition placenta accreta spectrum disorders (PAS) introduced by FIGO (International Federation of Gynaecology and Obstetrics) indicates an abnormal, pathological adherence or invasion of the placenta. The growing worldwide incidence of this pathological entity, and the possible serious correlated surgical risks, has caused a significant increase in attention among the scientific community. Previous caesarean delivery and presence of placenta previa are the main risk factors for the onset of PAS. Here, we present the intriguing case of a 39-year-old woman, at the 33rd week of gestation,

APA, Harvard, Vancouver, ISO, and other styles

29

Azouz, Eya, Omri Ahlem, Haithem Aloui, et al. "Magnetic Resonance Imaging Findings of Placenta Accreta Spectrum Disorder: A Pictorial Review." Topics in Magnetic Resonance Imaging 33, no. 6 (2024): e0315. https://doi.org/10.1097/rmr.0000000000000315.

Full text

Abstract:

Abstract: Magnetic resonance imaging (MRI) is used for diagnosing placenta accreta spectrum disorders (PASDs) because of its advanced soft-tissue contrast and spatial resolution capabilities, offering better contrast, improved spatial resolution, and a wider field of view compared with ultrasound. Using a 1.5-Tesla MRI protocol with multiple sequences, MRI can detect indicative signs of PASD such as placental signal heterogeneity, interruption of the myometrium-placenta interface, and abnormal vascularization. Specific sequences such as T2 SSFSE, FIESTA, and T1-weighted and diffusion-weighted

APA, Harvard, Vancouver, ISO, and other styles

30

Palacios-Jaraquemada, José Miguel, and Francesco D'Antonio. "Placenta Accreta Spectrum Disorder: Uterine Dehiscence, Not Placental Invasion." Obstetrics & Gynecology 136, no. 3 (2020): 631. http://dx.doi.org/10.1097/aog.0000000000004071.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Sabre, Alexander. "Placenta Accreta Spectrum Disorder: Uterine Dehiscence, Not Placental Invasion." Obstetrics & Gynecology 136, no. 3 (2020): 631–32. http://dx.doi.org/10.1097/aog.0000000000004072.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Kaba, Metin, Caglar Erkan, Mehmet Cihan Sarica, and Yeliz Akpinar Mayir. "Emergency hysterectomy after 2nd trimester abortion in a patient with placenta accreta spectrum disorder who had four cesarean deliveries." Česká gynekologie 88, no. 2 (2023): 110–13. http://dx.doi.org/10.48095/cccg2023110.

Full text

Abstract:

Objective: To perform an emergency hysterectomy by ligation of the uterine arteries before bladder dissection in a patient with placenta accreta spectrum disorder who developed excessive hemorrhage after abortion. Case report: A patient with four previous cesarean deliveries presented with pelvic pain and excessive vaginal bleeding following a fetal abortion. The patient’s hemodynamic status worsened. The patient underwent surgery, and the bladder was densely adherent to the previous incision scar. A classic hysterectomy was performed up to the level of the uterine artery bilaterally. The uter

APA, Harvard, Vancouver, ISO, and other styles

33

O.V., Golyanovskiy, Fedorenko D.S., Roshchina G.F. та Heints N.Ye. "Clinical case of delivery of a pregnant woman with Placenta previa/percreta 3с by modified cesarean section technique". Reproductive Health of Woman, № 3 (18 червня 2024): 47–52. https://doi.org/10.30841/2708-8731.3.2024.306407.

Full text

Abstract:

Placenta accreta spectrum (PAS) is a severe obstetric pathology, in which placental tissue invades the myometrium. According to the current classification of FIGO (2019), depending on the depth of placental tissue invasion, PAS is divided into Placenta accreta – about 75% of cases, Placenta increta – 15% and Placenta percreta – up to 10% of all cases.The most severe cases associated with the delivery of pregnant women with Placenta percreta, especially with placental tissue sprouting not only the myometrium of the front wall of the uterus, but also the back wall of the urinar

APA, Harvard, Vancouver, ISO, and other styles

34

Umeh, Uchenna Anthony, George Uchenna Eleje, Justus Uchenna Onuh, et al. "Comparison of Placenta Previa and Placenta Accreta Spectrum Disorder Following Previous Cesarean Section between Women with a Short and Normal Interpregnancy Interval." Obstetrics and Gynecology International 2022 (August 3, 2022): 1–9. http://dx.doi.org/10.1155/2022/8028639.

Full text

Abstract:

Objectives. The aim of this study is to determine the effect of interpregnancy interval (IPI) on the incidence of placenta previa and placenta accreta spectrum disorders in women with a previous cesarean section. Methods. A prospective cohort three-center study involving parturients who had previous cesarean section was conducted. Participants were included if pregnancy has lasted up to 34 weeks. Parturients with co-existing uterine fibroids, multiple gestations, premature rupture of membranes, and those with prior postcesarean delivery wound infection were excluded. The eligible women recruit

APA, Harvard, Vancouver, ISO, and other styles

35

Kirillova, Elizaveta A., Elena S. Semenova, Polina V. Kozlova, Elena D. Vyshedkevich, and Irina A. Mashchenko. "Abnormal hypervascularity in placenta accreta spectrum disorders: when to expect severe blood loss during surgical delivery." Digital Diagnostics 5, no. 1S (2024): 74–76. http://dx.doi.org/10.17816/dd626016.

Full text

Abstract:

BACKGROUND: One of the principal indications of placenta accreta is pathological vascular remodeling in the region of the placental site. This phenomenon, which may result from various mechanisms, can give rise to significant blood loss in women undergoing cesarean section [2]. AIM: The study aims to evaluate the correlation between different types of abnormal hypervascularization observed on pelvic magnetic resonance imaging in pregnant women with placenta accreta and blood loss during surgical delivery by cesarean section. MATERIALS AND METHODS: A total of 224 patients in the second and thir

APA, Harvard, Vancouver, ISO, and other styles

36

Slavov, Sergei. "Placenta accreta spectrum disorders in pregnancies following in vitrofertilization." MOJ Women's Health 10, no. 3 (2021): 70–72. http://dx.doi.org/10.15406/mojwh.2021.10.00291.

Full text

Abstract:

Placenta previa and related pregnancy complications are more common in In vitro fertilization pregnancies compared with spontaneous ones. There is evidence that PAS disorders are more common in pregnancies after IVF. Factors leading to a higher incidence of this pathology in IVF pregnancies have not been fully studied. Possible causes are the advanced age of women undergoing IVF, factors related to infertility itself, causes from the biological part of the In vitro procedure or controlled ovarian stimulation. The study of these factors is crucial for clinical practice as it would improve the o

APA, Harvard, Vancouver, ISO, and other styles

37

Morlando, Maddalena, and Sally Collins. "Placenta Accreta Spectrum Disorders: Challenges, Risks, and Management Strategies." International Journal of Women's Health Volume 12 (November 2020): 1033–45. http://dx.doi.org/10.2147/ijwh.s224191.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Matsubara, Shigeki, Hironori Takahashi, Yuji Takei, and Yasushi Imai. "Methotrexate for placenta accreta spectrum disorders: Is it needed?" Journal of Clinical Pharmacy and Therapeutics 45, no. 2 (2020): 399–400. http://dx.doi.org/10.1111/jcpt.13120.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Jauniaux, Eric, and Diogo Ayres-de-Campos. "FIGO consensus guidelines on placenta accreta spectrum disorders: Introduction,." International Journal of Gynecology & Obstetrics 140, no. 3 (2018): 261–64. http://dx.doi.org/10.1002/ijgo.12406.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Jauniaux, Eric, Frederic Chantraine, Robert M. Silver, and Jens Langhoff-Roos. "FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology,." International Journal of Gynecology & Obstetrics 140, no. 3 (2018): 265–73. http://dx.doi.org/10.1002/ijgo.12407.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Kaabia, O., B. Chemli, S. Ernez, A. Alimi, R. Bouchahda, and A. Chaieb. "EP16.17: Spectrum of placenta accreta disorders: an epidemiological profile." Ultrasound in Obstetrics & Gynecology 62, S1 (2023): 200–201. http://dx.doi.org/10.1002/uog.26911.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Wu, Xiafei, Huan Yang, Xinyang Yu, et al. "The prenatal diagnostic indicators of placenta accreta spectrum disorders." Heliyon 9, no. 5 (2023): e16241. http://dx.doi.org/10.1016/j.heliyon.2023.e16241.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Warrick, C. M., J. C. Markley, M. K. Farber, et al. "Placenta Accreta Spectrum Disorders: Knowledge Gaps in Anesthesia Care." Obstetric Anesthesia Digest 43, no. 1 (2023): 28–29. http://dx.doi.org/10.1097/01.aoa.0000912316.39661.a9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Solomon-Condriuc, Iustina Petra. "Diagnosis and management challenges of placenta accreta spectrum disorders." Revista Medico-Chirurgicala 128, no. 4 (2024): 774–83. https://doi.org/10.22551/msj.2024.04.11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Matthews, Kathy C., Andrew S. Quinn, and Stephen T. Chasen. "Potentially Preventable Primary Cesarean Sections in Future Placenta Accreta Spectrum." American Journal of Perinatology 39, no. 02 (2021): 120–24. http://dx.doi.org/10.1055/s-0041-1739493.

Full text

Abstract:

Objective Prior cesarean delivery is a well-known risk factor for placenta accreta spectrum disorders. While primary cesarean section is unavoidable in some patients, in others it may not be clearly indicated. The aim of the study is to determine the proportion of patients with placenta accreta spectrum who had a potentially preventable primary cesarean section and to identify factors associated with preventable placenta accreta spectrum. Study Design This was a single-center retrospective cohort study of women with pathology-confirmed placenta accreta spectrum from 2007 to 2019. Primary cesar

APA, Harvard, Vancouver, ISO, and other styles

46

Khan, Fatima Sharif, Beenish Khan, Kaswar Sajjad Ansari, Munnaza Andleeb, Surayya Jabeen, and Syeda Uzma. "Correlation of Placenta Accreta Index with Maternal Outcomes in Patients with Morbidly Adherent Placenta." Pakistan Armed Forces Medical Journal 74, no. 6 (2024): 1593–98. https://doi.org/10.51253/pafmj.v74i6.10291.

Full text

Abstract:

Objective: To assess the correlation of a novel scoring system, placenta accreta index with maternal outcomes in placenta accreta spectrum disorders. Study Design: Prospective longitudinal study Place and Duration of Study: Obstetrics and Gynecology Department of Combined Military Hospital Quetta, Pakistan from Apr 2022- Mar 2023. Methodology: A comparative study was carried out at Combined Military Hospital, Quetta after ethical approval. The study spanned over a year from April 2022 to March 2023. Thirty patients in second and third trimester of pregnancy with suspicion of placenta accreta o

APA, Harvard, Vancouver, ISO, and other styles

47

Harun, Muhammad Hairie Hakimi, Roziana Ramli, Nurul Atiah Mohd Ali, and Nor Jumizah Abd Kadir. "Placenta accreta spectrum disorder complicating a second trimester miscarriage." BMJ Case Reports 18, no. 2 (2025): e263686. https://doi.org/10.1136/bcr-2024-263686.

Full text

Abstract:

Placenta accreta spectrum (PAS) disorder is a potentially life-threatening condition which rarely complicates second trimester miscarriages. This report describes a woman who was pregnant at 17 weeks with a history of previous caesarean section and uterine curettage. She presented with hypovolaemic shock following massive per-vaginal bleeding at home. A 180 g fetus was spontaneously aborted, but the placenta was retained in the uterus. After resuscitation, she underwent surgery, during which a morbidly adherent placenta was identified necessitating an emergency hysterectomy. Histopathological

APA, Harvard, Vancouver, ISO, and other styles

48

Wilda Suci Hidayah and Moh Ilham Nur Baha. "The Analysis Study of High-intensity Focused Ultrasound in Management of Placenta Accreta Spectrum: A Comprehensive Systematic Review." International Journal of Medical Science and Health Research 6, no. 2 (2024): 42–61. http://dx.doi.org/10.70070/d0hf6028.

Full text

Abstract:

Background: Placenta Accreta Spectrum (PAS) refers to a group of abnormal placental invasion disorders involving the uterine wall. High-Intensity Focused Ultrasound (HIFU) has emerged as a promising non-invasive treatment modality for PAS. This systematic review aims to evaluate the clinical outcomes associated with HIFU in the management of PAS. Methods: The study followed PRISMA 2020 guidelines, reviewing English-language publications from 2014 to 2024. Editorials, duplicate reviews from the same journal, and papers lacking a DOI were excluded. The literature search was conducted using PubMe

APA, Harvard, Vancouver, ISO, and other styles

49

Alam, Dr Sonia, Dr Nasrin Akter, Dr Tanzin Hossain, Dr Arifa Akter Zahan Shoma, and Dr Arifa Akhter. "Role of Transabdominal Color Doppler Ultrasound in the Evaluation for Antenatal Diagnosis of Placenta Accreta Spectrum Disorder in Women with Placenta Previa." Scholars International Journal of Obstetrics and Gynecology 8, no. 06 (2025): 199–207. https://doi.org/10.36348/sijog.2025.v08i06.001.

Full text

Abstract:

Background: Placenta accreta is a severe pregnancy complication causing postpartum hemorrhage, bladder injury, and peripartum hysterectomy. Ultrasonography for antenatal diagnosis of PAS disorder has shown reduced maternal morbidity and death, making it crucial for management. This study determined the diagnostic value of ultrasound for the antenatal diagnosis of placenta accreta spectrum in women with placenta previa. Methods: This prospective observational study was conducted in the Department of Obstetrics and Gynaecology of Dhaka Medical College from June 2022 to May 2023. Forty pregnant w

APA, Harvard, Vancouver, ISO, and other styles

50

Plakhotina, E. N., T. N. Belousova, I. A. Kulikov, R. V. Latyshev, and K. M. Pavlyutina. "The Choice of Anesthesia During Organ-Saving Operations Concerning Patients With Placenta Accreta Spectrum Disorders." Russian Sklifosovsky Journal "Emergency Medical Care" 9, no. 2 (2020): 221–30. http://dx.doi.org/10.23934/2223-9022-2020-9-2-221-230.

Full text

Abstract:

Abstract Placenta accreta (PAS-disorders) is one of the most serious complications of pregnancy, associated with the risk of massive uterine bleeding, massive hemotransfusion and maternal mortality. Peripartum hysterectomy is a common treatment strategy for patients with placenta accreta. Currently, there is a clear trend of changing surgical tactics in favor of organ-saving operations, but there are no studies devoted to anesthesiological support of such operations.The aim of the study is to substantiate an effective and safe method of anaesthesia in organ-saving operations for placenta accre

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!